Cargando…

Persistent Reaction to Bacitracin after Patch Testing with Thin Layer Rapid Use Epicutaneous Test

Long-lasting allergic patch test reactions (LLAPTR) are reactions that remain positive for two weeks or more after the application of the allergen. LLAPTR of longer than 6 weeks duration is rarely seen. Here we present a 54-year-old female patient who had a positive allergic reaction to bacitracin w...

Descripción completa

Detalles Bibliográficos
Autores principales: Uyar, Belkız, Acar, Emine Müge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Dermatological Association; The Korean Society for Investigative Dermatology 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992647/
https://www.ncbi.nlm.nih.gov/pubmed/33911761
http://dx.doi.org/10.5021/ad.2020.32.4.331
_version_ 1783669419349639168
author Uyar, Belkız
Acar, Emine Müge
author_facet Uyar, Belkız
Acar, Emine Müge
author_sort Uyar, Belkız
collection PubMed
description Long-lasting allergic patch test reactions (LLAPTR) are reactions that remain positive for two weeks or more after the application of the allergen. LLAPTR of longer than 6 weeks duration is rarely seen. Here we present a 54-year-old female patient who had a positive allergic reaction to bacitracin with the thin layer rapid use epicutaneous test (TRUE test), which lasted for about 11 weeks duration. To our knowledge this is the first reported case of LLAPTR related to the bacitracin.
format Online
Article
Text
id pubmed-7992647
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher The Korean Dermatological Association; The Korean Society for Investigative Dermatology
record_format MEDLINE/PubMed
spelling pubmed-79926472021-04-27 Persistent Reaction to Bacitracin after Patch Testing with Thin Layer Rapid Use Epicutaneous Test Uyar, Belkız Acar, Emine Müge Ann Dermatol Case Report Long-lasting allergic patch test reactions (LLAPTR) are reactions that remain positive for two weeks or more after the application of the allergen. LLAPTR of longer than 6 weeks duration is rarely seen. Here we present a 54-year-old female patient who had a positive allergic reaction to bacitracin with the thin layer rapid use epicutaneous test (TRUE test), which lasted for about 11 weeks duration. To our knowledge this is the first reported case of LLAPTR related to the bacitracin. The Korean Dermatological Association; The Korean Society for Investigative Dermatology 2020-08 2020-06-30 /pmc/articles/PMC7992647/ /pubmed/33911761 http://dx.doi.org/10.5021/ad.2020.32.4.331 Text en Copyright © 2020 The Korean Dermatological Association and The Korean Society for Investigative Dermatology http://creativecommons.org/licenses/by-nc/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Uyar, Belkız
Acar, Emine Müge
Persistent Reaction to Bacitracin after Patch Testing with Thin Layer Rapid Use Epicutaneous Test
title Persistent Reaction to Bacitracin after Patch Testing with Thin Layer Rapid Use Epicutaneous Test
title_full Persistent Reaction to Bacitracin after Patch Testing with Thin Layer Rapid Use Epicutaneous Test
title_fullStr Persistent Reaction to Bacitracin after Patch Testing with Thin Layer Rapid Use Epicutaneous Test
title_full_unstemmed Persistent Reaction to Bacitracin after Patch Testing with Thin Layer Rapid Use Epicutaneous Test
title_short Persistent Reaction to Bacitracin after Patch Testing with Thin Layer Rapid Use Epicutaneous Test
title_sort persistent reaction to bacitracin after patch testing with thin layer rapid use epicutaneous test
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992647/
https://www.ncbi.nlm.nih.gov/pubmed/33911761
http://dx.doi.org/10.5021/ad.2020.32.4.331
work_keys_str_mv AT uyarbelkız persistentreactiontobacitracinafterpatchtestingwiththinlayerrapiduseepicutaneoustest
AT acareminemuge persistentreactiontobacitracinafterpatchtestingwiththinlayerrapiduseepicutaneoustest